Liver disease symptoms in non-alcoholic fatty liver disease and small intestinal bacterial overgrowth

Rafiei, Rahmatollah; Bemanian, Mahboobeh; Rafiei, Fereshteh; Bahrami, Mahmood; Fooladi, Lotfollah; Ebrahimi, Giti; Hemmat, Ahmadreza; Torabi, Zahra

Liver disease symptoms in non-alcoholic fatty liver disease and small intestinal bacterial overgrowth

Volume 56 (2018): Issue 2 (June 2018)

By:

Rahmatollah Rafiei, Mahboobeh Bemanian, Fereshteh Rafiei, Mahmood Bahrami, Lotfollah Fooladi, Giti Ebrahimi, Ahmadreza Hemmat and Zahra Torabi

Open Access

|May 2018

References

1. CALDWELL SH., CRESPO DM. The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease. J Hepatol. 2004; 40(4):578-84.
Search in Google Scholar Back to article
2. LONARDO A., BYRNE C., CALDWELL S., CORTEZ-PINTO H., TARGHER G. Global epidemiology of nonalcoholic fatty liver disease: Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016; 64: 1388-1389.10.1002/hep.28584
Open DOI Search in Google Scholar Back to article
3. FAN JG., SAIBARA T., CHITTURI S., KIM BI., SUNG JJ., CHUTAPUTTI A. What are the risk factors and settings for nonalcoholic fatty liver disease in Asia–Pacific? J Gastroenterol Hepatol. 2007; 22(6):794-800.10.1111/j.1440-1746.2007.04952.x
Search in Google Scholar Back to article
4. OGDEN CL., CARROLL MD., CURTIN LR., LAMB MM., FLEGAL KM. Prevalence of high body mass index in US children and adolescents, 2007-2008. JAMA. 2010; 303(3):242-9.10.1001/jama.2009.2012
Search in Google Scholar Back to article
5. GAGGINI M., MORELLI M., BUZZIGOLI E., DEFRONZO RA., BUGIANESI E., GASTALDELLI A. Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients. 2013; 5(5):1544-60.10.3390/nu5051544
Search in Google Scholar Back to article
6. AL-BUSAFI SA., BHAT M., WONG P., GHALI P., DESCHENES M. Antioxidant therapy in nonalcoholic steatohepatitis. Hepat Res Treat. 2012; 22: 947575.10.1155/2012/947575
Search in Google Scholar Back to article
7. VIGANÒ M., VERGANI A., TROMBINI P., POZZI M., PALEARI F., PIPERNO A. Insulin resistance influences iron metabolism and hepatic steatosis in type II diabetes. Gastroenterology. 2000; 118(5):986-7.10.1016/S0016-5085(00)70193-4
Open DOI Search in Google Scholar Back to article
8. COHEN B., NOVICK D., RUBINSTEIN M. Modulation of insulin activities by leptin. Science. 1996; 274(5290):1185.10.1126/science.274.5290.11858895466
Search in Google Scholar Back to article
9. PAPPO I., BERCOVIER H., BERRY E., GALLILLY R., FEIGIN E., FREUND HR. Antitumor necrosis factor antibodies reduce hepatic steatosis during total parenteral nutrition and bowel rest in the rat. J Parenter Enteral Nutr. 1995; 19(1):80-2.10.1177/0148607195019001807658606
Search in Google Scholar Back to article
10. KIRSCH R., CLARKSON V., VERDONK RC., MARAIS AD., SHEPHARD EG., RYFFEL B., et al. Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency. J Gastroenterol Hepatol. 2006; 21(1):174-82.10.1111/j.1440-1746.2005.04220.x16706830
Search in Google Scholar Back to article
11. BOND JR JH., LEVITT MD. Use of pulmonary hydrogen (H2) measurements to quantitate carbohydrate absorption: study of partially gastrectomized patients. J Clin Invest. 1972; 51(5):1219.10.1172/JCI1069162922535020434
Open DOI Search in Google Scholar Back to article
12. SABATÉ J-M., JOUËT P., HARNOIS F., MECHLER C., MSIKA S., GROSSIN M., et al. High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis. Obes Surg. 2008; 18(4):371-7.10.1007/s11695-007-9398-2
Open DOI Search in Google Scholar Back to article
13. CORAZZA GR., STROCCHI A., GASBARRINI G. Fasting breath hydrogen in celiac disease. Gastroenterology. 1987; 93(1):53-8.10.1016/0016-5085(87)90313-1
Search in Google Scholar Back to article
14. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circulation. 2002; 106:3143-3421.10.1161/circ.106.25.3143
Search in Google Scholar Back to article
15. WIGG A., ROBERTS-THOMSON I., DYMOCK R., MCCARTHY P., GROSE R., CUMMINS A. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor α in the pathogenesis of non-alcoholic steatohepatitis. Gut. 2001; 48(2):206-11.10.1136/gut.48.2.206172821511156641
Open DOI Search in Google Scholar Back to article
16. SHANAB AA., SCULLY P., CROSBIE O., BUCKLEY M., O’MAHONY L., SHANAHAN F., et al. Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8. Dig Dis Sci. 2011; 56(5):1524-34.10.1007/s10620-010-1447-321046243
Search in Google Scholar Back to article
17. RUIZ AG., CASAFONT F., CRESPO J., CAYÓN A., MAYORGA M., ESTEBANEZ A., et al. Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis. Obes Surg. 2007; 17(10):1374-80.10.1007/s11695-007-9243-718000721
Search in Google Scholar Back to article
18. BELLOT P., FRANCÉS R., SUCH J. Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications. Liver Int. 2013; 33(1):31-9.10.1111/liv.1202123121656
Search in Google Scholar Back to article
19. WIEST R., LAWSON M., GEUKING M. Pathological bacterial translocation in liver cirrhosis. J Hepatol. 2014; 60(1):197-209.10.1016/j.jhep.2013.07.04423993913
Search in Google Scholar Back to article
20. GUPTA A., DHIMAN RK., KUMARI S., RANA S., AGARWAL R., DUSEJA A., et al. Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy. J Hepatol. 2010; 53(5):849-55.10.1016/j.jhep.2010.05.01720675008
Open DOI Search in Google Scholar Back to article
21. MIELE L., VALENZA V., LA TORRE G., MONTALTO M., CAMMAROTA G., RICCI R., et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology. 2009; 49(6):1877-87.10.1002/hep.2284819291785
Search in Google Scholar Back to article
22. PARNELL JA., RAMAN M., RIOUX KP., REIMER RA. The potential role of prebiotic fibre for treatment and management of non-alcoholic fatty liver disease and associated obesity and insulin resistance. Liver Int. 2012; 32(5):701-11.10.1111/j.1478-3231.2011.02730.x22221818
Open DOI Search in Google Scholar Back to article
23. XU R-Y., WAN Y-P., FANG Q-Y., LU W., CAI W. Supplementation with probiotics modifies gut flora and attenuates liver fat accumulation in rat nonalcoholic fatty liver disease model. J Clin Biochem Nutr. 2011; 50(1):72-7.10.3164/jcbn.11-38324618622247604
Search in Google Scholar Back to article
24. PARLESAK A., KLEIN B., SCHECHER K., BODE JC., BODE C. Prevalence of small bowel bacterial overgrowth and its association with nutrition intake in nonhospitalized older adults. J Am Geriatr Soc. 2003; 51(6):768-73.10.1046/j.1365-2389.2003.51259.x12757562
Open DOI Search in Google Scholar Back to article
25. ALKHOURI N., CIKACH F., ENG K., MOSES J., PATEL N., YAN C., et al. Analysis of breath volatile organic compounds as a noninvasive tool to diagnose nonalcoholic fatty liver disease in children. Eur J Gastroenterol Hepatol. 2014; 26:82-7.10.1097/MEG.0b013e328365066924284369
Search in Google Scholar Back to article

DOI: https://doi.org/10.1515/rjim-2017-0042 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749

Journal RSS Feed

Language: English

Page range: 85 - 89

Submitted on: Aug 8, 2017

Published on: May 17, 2018

Published by: N.G. Lupu Internal Medicine Foundation

In partnership with: Paradigm Publishing Services

Publication frequency: 4 times per year

Keywords:

Non-alcoholic fatty liver disease,

Small intestinal bacterial overgrowth,

Related subjects:

Internal medicine, other,

Cardiology,

Gastroenterology,

Rheumatology

© 2018 Rahmatollah Rafiei, Mahboobeh Bemanian, Fereshteh Rafiei, Mahmood Bahrami, Lotfollah Fooladi, Giti Ebrahimi, Ahmadreza Hemmat, Zahra Torabi, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 56 (2018): Issue 2 (June 2018)Next article